Renal cancer

Cinzia Ortega, Camillo Porta, Manuela Racca, Filippo Russo

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Renal cell carcinoma (RCC) represents 2-3% of all cancers, with the highest incidence in Western countries and particularly in Europe, where the annual increase in the incidence of this disease is 2% [1, 2]. More than 50% of RCCs are diagnosed incidentally and are asymptomatic. The classic triad of flank pain, gross hematuria, and a palpable abdominal mass is seen in very few patients (6-10%). Paraneoplastic symptoms (e.g., hypertension, weight loss, pyrexia, neuromyopathy, anemia, polycythemia, amyloidosis, elevated erythrocyte sedimentation rate, and abnormal liver function) are found in approximately 20-30% of patients with RCC and about 20-30% of all RCC patients have metastatic disease.

Original languageEnglish
Title of host publicationImaging Tumor Response to Therapy
PublisherSpringer-Verlag Italia s.r.l.
Pages61-75
Number of pages15
ISBN (Print)9788847026131, 9788847026124
DOIs
Publication statusPublished - Jan 1 2012

Fingerprint

Kidney Neoplasms
Renal Cell Carcinoma
Sedimentation
Liver
Flank Pain
Polycythemia
Blood Sedimentation
Incidence
Cells
Amyloidosis
Hematuria
Anemia
Weight Loss
Fever
Hypertension
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ortega, C., Porta, C., Racca, M., & Russo, F. (2012). Renal cancer. In Imaging Tumor Response to Therapy (pp. 61-75). Springer-Verlag Italia s.r.l.. https://doi.org/10.1007/978-88-470-2613-1_4

Renal cancer. / Ortega, Cinzia; Porta, Camillo; Racca, Manuela; Russo, Filippo.

Imaging Tumor Response to Therapy. Springer-Verlag Italia s.r.l., 2012. p. 61-75.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ortega, C, Porta, C, Racca, M & Russo, F 2012, Renal cancer. in Imaging Tumor Response to Therapy. Springer-Verlag Italia s.r.l., pp. 61-75. https://doi.org/10.1007/978-88-470-2613-1_4
Ortega C, Porta C, Racca M, Russo F. Renal cancer. In Imaging Tumor Response to Therapy. Springer-Verlag Italia s.r.l. 2012. p. 61-75 https://doi.org/10.1007/978-88-470-2613-1_4
Ortega, Cinzia ; Porta, Camillo ; Racca, Manuela ; Russo, Filippo. / Renal cancer. Imaging Tumor Response to Therapy. Springer-Verlag Italia s.r.l., 2012. pp. 61-75
@inbook{b8993b6d60934915ad4e847dbd620edd,
title = "Renal cancer",
abstract = "Renal cell carcinoma (RCC) represents 2-3{\%} of all cancers, with the highest incidence in Western countries and particularly in Europe, where the annual increase in the incidence of this disease is 2{\%} [1, 2]. More than 50{\%} of RCCs are diagnosed incidentally and are asymptomatic. The classic triad of flank pain, gross hematuria, and a palpable abdominal mass is seen in very few patients (6-10{\%}). Paraneoplastic symptoms (e.g., hypertension, weight loss, pyrexia, neuromyopathy, anemia, polycythemia, amyloidosis, elevated erythrocyte sedimentation rate, and abnormal liver function) are found in approximately 20-30{\%} of patients with RCC and about 20-30{\%} of all RCC patients have metastatic disease.",
author = "Cinzia Ortega and Camillo Porta and Manuela Racca and Filippo Russo",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-88-470-2613-1_4",
language = "English",
isbn = "9788847026131",
pages = "61--75",
booktitle = "Imaging Tumor Response to Therapy",
publisher = "Springer-Verlag Italia s.r.l.",

}

TY - CHAP

T1 - Renal cancer

AU - Ortega, Cinzia

AU - Porta, Camillo

AU - Racca, Manuela

AU - Russo, Filippo

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Renal cell carcinoma (RCC) represents 2-3% of all cancers, with the highest incidence in Western countries and particularly in Europe, where the annual increase in the incidence of this disease is 2% [1, 2]. More than 50% of RCCs are diagnosed incidentally and are asymptomatic. The classic triad of flank pain, gross hematuria, and a palpable abdominal mass is seen in very few patients (6-10%). Paraneoplastic symptoms (e.g., hypertension, weight loss, pyrexia, neuromyopathy, anemia, polycythemia, amyloidosis, elevated erythrocyte sedimentation rate, and abnormal liver function) are found in approximately 20-30% of patients with RCC and about 20-30% of all RCC patients have metastatic disease.

AB - Renal cell carcinoma (RCC) represents 2-3% of all cancers, with the highest incidence in Western countries and particularly in Europe, where the annual increase in the incidence of this disease is 2% [1, 2]. More than 50% of RCCs are diagnosed incidentally and are asymptomatic. The classic triad of flank pain, gross hematuria, and a palpable abdominal mass is seen in very few patients (6-10%). Paraneoplastic symptoms (e.g., hypertension, weight loss, pyrexia, neuromyopathy, anemia, polycythemia, amyloidosis, elevated erythrocyte sedimentation rate, and abnormal liver function) are found in approximately 20-30% of patients with RCC and about 20-30% of all RCC patients have metastatic disease.

UR - http://www.scopus.com/inward/record.url?scp=84957040365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957040365&partnerID=8YFLogxK

U2 - 10.1007/978-88-470-2613-1_4

DO - 10.1007/978-88-470-2613-1_4

M3 - Chapter

AN - SCOPUS:84957040365

SN - 9788847026131

SN - 9788847026124

SP - 61

EP - 75

BT - Imaging Tumor Response to Therapy

PB - Springer-Verlag Italia s.r.l.

ER -